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Abstract
Background: During the development of an enantioselective synthesis using the lipase from Mucor
miehei an unusual reaction course was observed, which was analyzed precisely. For the first time
an allosteric modulation of a lipase changing its selectivity was shown.
Theory:  Considering the biological relevance of the discovered regulation mechanism we
developed a theory that describes the regulation of energy homeostasis and fat metabolism.
Conclusion: This theory represents a new approach to explain the cause of the metabolic
syndrome and provides an innovative basis for further research activity.
Background
Introduction
Asymmetric syntheses are investigated to produce chiral
organic compounds with high enantiomeric purity. Their
development has been an expending task of research dur-
ing the last years. Valuable tools to perform the required
chemical reactions are enzymes, which work as catalysts.
The substrate to be transformed binds to the chiral bind-
ing site of the employed enzyme and is modified enanti-
oselectively. Very often lipases are used for this kind of
transformation [1,2]. In water these enzymes catalyze the
hydrolysis of esters to afford alcohols and acids. This reac-
tion corresponds to their natural task, hydrolysis of trig-
lycerides. Their catalytic activity is increased by interfacial
activation [3]. Since lipases are also stable and active in
neat organic solvents, their use as catalysts is very conven-
ient. In organic solvents the equilibrium of the catalyzed
reaction is shifted to the direction of esters, which are
formed instead of hydrolyzed. Often transesterfications
are carried out to produce esters from alcohols. The most
useful acyl donors for this feature are enol esters, e.g. vinyl
or isopropenyl acetate, as the resulting enols tautomerize
into carbonyl compounds. This procedure makes the reac-
tion almost irreversible [4].
In our experiments two different lipases were used. We
employed the lipase from Burkholderia cepacia and the
lipase from Mucor miehei, which are common in organic
synthesis. In numerous publications both lipases were
investigated and described in detail, their tertiary struc-
tures have been characterized by X-ray structure analysis
[2-7]. Due to reclassification Burkholderia cepacia was
renamed during the last years. Therefore the lipase origi-
nating from this bacterium can also be labeled as lipase
from  Pseudomonas species,  Pseudomonas cepacia or  Pseu-
domonas fluoreszens. The preparation we used in our exper-
iments is commercially available as Amano lipase PS-CII,
which is the lipase from B. cepacia immobilized on
ceramic particles. The immobilized enzyme forms better
suspensions in organic solvents, has an increased activity,
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can be recycled by filtration and is therefore more conven-
ient to use.
The lipase from Mucor miehei is also found as lipase from
Rhizomucor miehei. Both its amino acid sequence and ter-
tiary structure are known [8-10]. Like almost all other
lipases the lipase from M. miehei also shows interfacial
activation due to a lid at its active site, which can switch
between a closed and open form. The genetic information
of this lipase was inserted into Aspergillus oryzae [11].
Thus, the lipase from Mucor miehei is inexpensively avail-
able in pure form and great amounts using this expression
vector [12]. The preparation, which was used in our exper-
iments, was produced by this procedure and immobilized
on an ion-exchange resin. It is commercially available
from Novo Nordisk as Lipozyme®.
Findings
Herein, we describe the asymmetric transformation of a
prochiral diol with the lipases from Burkholderia cepacia
and Mucor miehei. The detailed reaction conditions of the
experiments, the spectroscopic and analytical data of all
products and the employed procedures were published
recently [13]. The relevant part of the work is summarized
as follows:
The synthesis was started from prochiral diester 1, which
was silylated with chloro-dimethyl-phenyl-silane. The
resulting silyl ether 2 was reduced to give the prochiral
pentanediol 3 (Fig. 1).
The lipase should acetylate the prochiral diol 3 enantiose-
lectively by irreversible transesterification with isoprope-
nyl acetate (IPA) using tert-butyl methyl ether (TBME) as
solvent to provide enantiopure monoacetate (S)-4 (Fig.
2).
However, acetylation of the prochiral diol 3 can take place
at either of the OH groups to yield the enantiomeric
monoacetates (S)-4 and (R)-4 or at both OH groups to
provide the prochiral diacetate 5 (Fig. 3). In order to illus-
trate this reaction sequence, contour plots representing
the structural features of the respective chemical com-
pounds are introduced in Figure 3.
The lipase catalyzed acetylation of diol 3 was monitored
by HPLC analysis of samples taken from the reaction mix-
ture using an achiral RP-18 column as well as a chiral col-
umn. In this way the development of the amounts of
substances 3, 4 and 5 and the development of the enanti-
omeric excess of monoacetate (S)-4 were recorded and
displayed as reaction courses. The absolute configuration
of monoacetate (S)-4 was determined by CD spectroscopy
[13].
In the first step of the reaction both lipases catalyzed the
acetylation of diol 3 yielding preferentially the (S)-config-
ured monoacetate (S)-4. The enantiomeric excess
increased during the progress of the reaction, because the
small amount of formed (R)-configured monoacetate (R)-
4 containing the preferred free OH-group was acetylated
faster than (S)-4 to provide the prochiral diacetate 5 in the
second step of the reaction (Figure 4).
However, the reaction courses produced by the lipases
from Burkholderia cepacia and Mucor miehei differed in a
very interesting manner (Fig. 5a, b and Fig. 5c, d). The
reaction catalyzed by the lipase from M. miehei led to a
higher concentration of monoacetate 4  during the
progress of the reaction (Fig. 5c) than the lipase from B.
cepacia (Fig. 5a). This is an amazing result, since the enan-
tiomeric excess of (S)-4 produced by the lipase from B.
cepacia (Fig. 5b) was higher than the one produced by the
lipase from M. miehei (Fig. 5d). Obviously diol 3  was
Lipase catalyzed enantioselective, irreversible acetylation Figure 2
Lipase catalyzed enantioselective, irreversible acetylation.
OH HO
O
H3C O
CH2
O HO
H3C O
CH3
lipase
+ +
(S)
3 (S)-4
IPA
TBME
Si H3C CH3
O
Si H3C CH3
CH3
O
CH3
O
Synthesis of the prochiral diol 3 Figure 1
Synthesis of the prochiral diol 3.
MeO2C CO2Me
O
Si CH3 H3C
HO OH
O
Si CH3 H3C
MeO2C CO2Me
OH
Me2PhSiCl
CH2Cl2
imidazole
LiBH4
Et2O
1
3
2Theoretical Biology and Medical Modelling 2007, 4:34 http://www.tbiomed.com/content/4/1/34
Page 3 of 16
(page number not for citation purposes)
acetylated selectively by the lipase from M. miehei to give
the monoacetates (S)-4 and (R)-4 in the first step of the
reaction. The second acetylation of both monoacetates
(S)-4 and (R)-4 did not take place until diol 3 was con-
sumed almost completely. The explanation for this unu-
sual observation is discussed in the following parts of the
manuscript.
Computer simulation
Helpful for the interpretation of the results described
above is a computer simulation of the processes using a
mathematical model of the reaction scheme shown in Fig-
ure 3. According to this mathematical model the reaction
course is divided into several small time intervals within
the reaction conditions can assumed to be constant [14].
The progress of the reaction is simulated by subdividing
the activity of the catalyst according to the competing
reactions. It is considered that the compounds react
according to their current concentration, their respective
affinity towards the lipase and the rate constant of the pro-
Progress of the reaction carried out at +20°C; a, c, e:  Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio- meric excess of (S)-4 (% ee); a, b: Transformation catalyzed  by lipase from B. cepacia; c, d: Transformation catalyzed by  lipase from M. miehei; e, f: Simulation of the reaction using a  constant lipase activity a = 0.004 [14]; The rate constants k1  to k8 are defined in Figure 3; k1 = 15, k2 = 1, k3 = 4, k4 = 60, k5  = 15·10-6, k6 = 1·10-6, k7 = 4·10-6, k8 = 60·10-6 Figure 5
Progress of the reaction carried out at +20°C; a, c, e: 
Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio-
meric excess of (S)-4 (% ee); a, b: Transformation catalyzed 
by lipase from B. cepacia; c, d: Transformation catalyzed by 
lipase from M. miehei; e, f: Simulation of the reaction using a 
constant lipase activity a = 0.004 [14]; The rate constants k1 
to k8 are defined in Figure 3; k1 = 15, k2 = 1, k3 = 4, k4 = 60, k5 
= 15·10-6, k6 = 1·10-6, k7 = 4·10-6, k8 = 60·10-6.
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Lipase catalyzed acetylation of the prochiral diol 3 Figure 3
Lipase catalyzed acetylation of the prochiral diol 3.
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ceeding partial reaction. This model was programmed as
a Microsoft® Excel spreadsheet and used to simulate the
investigated asymmetric transformations.
The prochiral diol 3 is converted into the (S)- or (R)-con-
figured monoacetates (S)-4 and (R)-4 with different reac-
tion rate constants k1 and k2 in the first reaction step. In
the second step the enantiomeric monoacetates (S)-4 and
(R)-4 are converted enantioselectively with different reac-
tion rate constants k3 or k4 to give the prochiral diacetate 5
(Figure 3). Thus, the four reaction rate constants k1 to k4
define the four possible acetylation reactions. As lipases
catalyze reaction equilibria, the corresponding backward
reactions defined by the reaction rate constants k5 to k8 can
also take place, theoretically. As outlined above the back-
ward reactions are prevented almost completely by
employing an enolester for transesterfication. Since the
forward reactions are almost irreversible, the correspond-
ing reaction equilibria are set to 106:1 on product side for
all simulations carried out (k1/k5 = k2/k6 = k3/k7 = k4/k8 =
106). In addition the activity of the lipase is defined by the
variable a. Thus, the properties of a given lipase can be
defined by setting values for its activity a and the reaction
rate constants k1 to k8.
Figure 5 (e, f) shows the simulated progress of a reaction
using a lipase with an enantioselectivity of 15:1 for both
acetylation steps (k1/k2 = k4/k3 = k5/k6 = k8/k7 = 15). It is
assumed that the second acetylation takes place four times
faster than the first one (k4/k1 = k3/k2 = k8/k5 = k7/k6 = 4)
and that the activity of the lipase remains constant (a =
0.004).
Allosteric effect
The comparison of the experimentally determined reac-
tion courses with the simulated ones leads to the follow-
ing results. The reaction performed with lipase from B.
cepacia corresponds to the prediction made by the simula-
tion (Fig. 5a, b and Fig. 5e, f). In further experiments it was
shown that the enantioselectivity of the lipase was
increased by lowering the reaction temperature, whereas
the selectivity to perform either the first or second acetyla-
tion step remained constant (Fig. 5a, b and Fig. 6a, b)
[13].
In contrast to the B. cepacia lipase catalyzed transforma-
tion the reaction course produced by the lipase from M.
miehei does not correspond to the simulation, provided
that the activity of the lipase remains constant during the
reaction time. It is remarkable that diacetate 5 was not
produced at the beginning of the reaction and the enanti-
omeric excess remained constant during this time period.
In order to verify the differing catalytic properties of the
two lipases the experiments were repeated at low temper-
ature. Figure 6 shows the progress of the reactions carried
out with the lipases from B. cepacia at -40°C (a, b) and M.
miehei at -10°C (c, d).
Once again the experimentally determined reaction
course produced by the lipase from B. cepacia is in good
agreement with the computer simulation (Fig. 6a, b and
Fig. 6e, f). On the contrary, the enantiomeric excess
remained constant again at the beginning of the reaction
using the lipase from M. miehei (Fig. 6d, compare Fig. 5d).
Due to the reaction kinetics a constant enantiomeric
excess is only possible, if the second acetylation of
monoacetates (S)-4 and (R)-4 into diacetate 5 proceeds
non-enantioselectively (k3 = k4 and k7 = k8) (Fig. 7a) or
does not take place (k3 = k4 = 0i→∞) (Fig. 7b).
Progress of the reaction carried out at low temperature; a, c,  e: Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio- meric excess of (S)-4 (% ee); a, b: Transformation catalyzed  by lipase from B. cepacia at -40°C; c, d: Transformation cata- lyzed by lipase from M. miehei at -10°C; e, f: Simulation of the  reaction using a constant lipase activity a = 0.004 [14]; The  rate constants k1 to k8 are defined in Figure [3]; k1 = 35, k2 =  1, k3 = 4, k4 = 140, k5 = 35·10-6, k6 = 1·10-6, k7 = 4·10-6, k8 =  140·10-6 Figure 6
Progress of the reaction carried out at low temperature; a, c, 
e: Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio-
meric excess of (S)-4 (% ee); a, b: Transformation catalyzed 
by lipase from B. cepacia at -40°C; c, d: Transformation cata-
lyzed by lipase from M. miehei at -10°C; e, f: Simulation of the 
reaction using a constant lipase activity a = 0.004 [14]; The 
rate constants k1 to k8 are defined in Figure 3; k1 = 35, k2 = 1, 
k3 = 4, k4 = 140, k5 = 35·10-6, k6 = 1·10-6, k7 = 4·10-6, k8 = 
140·10-6.
4
0
20
40
60
80
100
02468 1 0
•1000 intervals
n [%]
3 4 5
85
90
95
100
02468 1 0
•1000 intervals
% ee
(S)-4
0
20
40
60
80
100
0 50 100 150 200 250
time [h]
n [%]
3 4 5
85
90
95
100
0 50 100 150 200 250
time [h]
% ee
(S)-4
0
20
40
60
80
100
0 200 400 600 800
time [h]
n [%]
3 4 5
85
90
95
100
0 200 400 600 800
time [h]
% ee
(S)-4 (S)-4 a b
c d
e fTheoretical Biology and Medical Modelling 2007, 4:34 http://www.tbiomed.com/content/4/1/34
Page 5 of 16
(page number not for citation purposes)
In Figure 8 the progress of the reactions is simulated for
these supposed situations. A non-enantioselective second
acetylation of monoacetates (S)-4 and (R)-4 would result
in a rapid formation of diacetate 5 (Fig. 8a), which is not
seen in the experiment (Fig. 6c). According to the remain-
ing second possibility, the acetylation of monoacetates
(S)-4 and (R)-4 does not take place at the beginning of the
reaction (Fig. 8c, d). Obviously, an inhibition occurs,
which is reversed during the reaction.
However, this simulation does still not match the experi-
mental data exactly (Fig. 6c, d), since both the decrease of
diol 3 and the increase of monoacetate 4 proceeded line-
arly in the experiment. This indicates that the transforma-
tion does not depend on the concentration of compounds
3 and 4. Substrates 3, 4 and 5 do not compete with each
other, since only diol 3 can bind to the active site of the
lipase (Fig. 7c). However, the computer simulation used
up to now is mathematically based on a competition situ-
Simulated reaction courses using a constant lipase activity a  [14]; The rate constants k1 to k8 are defined in Figure 3; a, c,  e: Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio- meric excess of (S)-4 (% ee); a, b: non-enantioselective trans- formation of (S)-4 and (R)-4 into 5 (a = 0.0008); k1 = 17, k2 =  1, k3 = 9, k4 = 9, k5 = 17·10-6, k6 = 1·10-6, k7 = 9·10-6, k8 = 9·10- 6; c, d: inhibited transformation of (S)-4 and (R)-4 into 5 (a =  0.0004); k1 = 17, k2 = 1, k3 = 0.009, k4 = 0.009, k5 = 17·10-6, k6  = 1·10-6, k7 = 0.009·10-6, k8 = 0.009·10-6; e, f: non-competi- tive, since compounds 4 and 5 do not bind to the enzyme (a  = 0.02); k1 = 17, k2 = 1 Figure 8
Simulated reaction courses using a constant lipase activity a 
[14]; The rate constants k1 to k8 are defined in Figure 3; a, c, 
e: Amount of compounds 3, 4 and 5 (n [%]); b, d, f: Enantio-
meric excess of (S)-4 (% ee); a, b: non-enantioselective trans-
formation of (S)-4 and (R)-4 into 5 (a = 0.0008); k1 = 17, k2 = 
1, k3 = 9, k4 = 9, k5 = 17·10-6, k6 = 1·10-6, k7 = 9·10-6, k8 = 9·10-
6; c, d: inhibited transformation of (S)-4 and (R)-4 into 5 (a = 
0.0004); k1 = 17, k2 = 1, k3 = 0.009, k4 = 0.009, k5 = 17·10-6, k6 
= 1·10-6, k7 = 0.009·10-6, k8 = 0.009·10-6; e, f: non-competi-
tive, since compounds 4 and 5 do not bind to the enzyme (a 
= 0.02); k1 = 17, k2 = 1.
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ation and has to be modified to take the non-competitive
situation into account. Differing from literature [14] the
changes of the amounts of substances during a time inter-
val are then as follows:
∆n(3)i = - a
∆n((S)-4)i = a·d
∆n((R)-4)i = a·e
∆n(5)i = 0
Using these settings the simulation results in the same lin-
ear development of the amounts of diol 3 and monoace-
tate 4 as observed in the experiment at the beginning of
the reaction (Fig. 8e, compare Fig. 6c). Obviously the
lipase is modulated in a way that only diol 3 interacts with
the active binding site during this time period. Monoace-
tate 4 and diacetate 5 do not compete for the active site.
Hence, the reaction is subdivided into two time periods
with a different selectivity of the lipase (Fig. 9).
During time period A (Fig. 9a) the transformation of
monoacetate 4 into diacetate 5 is inhibited and does not
take place, as these compounds cannot bind (Fig. 10a).
During time period B (Fig. 9b) this inhibition is reversed
and monoacetate 4 is acetylated (Fig. 10b).
According to this observation the lipase from M. miehei is
modulated reversibly and inhibited selectively. However,
the question remains, whereby this modulation is
induced and reversed subsequently. The reason must be a
compound, which decreases in concentration during time
period A, so that the modulation is reversed at the begin-
ning of time period B due to its very low concentration.
This property is only given for diol 3. An activation of the
lipase caused by a compound increasing in concentration
is not possible, since this would lead to an increasing
activity of the lipase and therefore a non-linear change of
the amounts of compounds 3 and 4. Hence, diol 3 used as
a reactant must be the reason for the modulation of the
lipase. During time period A the transformation of
monoacetate 4 is inhibited by diol 3. Monoacetate 4 is
acetylated not until diol 3 is consumed almost quantita-
tively.
Inhibition of enzymes can be induced by inhibitors bind-
ing at the active site or allosterically. The former possibil-
ity is always competitive, because the inhibitor competes
with the substrate for the active site of the enzyme. A com-
petitive inhibition would lead to altering reaction rates
depending on the concentrations of compounds 3 and 4.
However, a change of the reaction rates was not observed
in our experiments. Independent on the concentrations
the reaction rates were constant during time period A.
Therefore the observed inhibition has to be induced allos-
terically. In this case the non-competitive and very rare
uncompetitive mechanism must be differentiated [15].
According to an uncompetitive mechanism diol 3 would
bind to the substrate-lipase-complex inhibiting its trans-
formation into diacetate-lipase-complex, but not inhibit-
ing its transformation into monoacetate-lipase-complex.
In this situation, the diol-lipase-complex and the monoa-
cetate-lipase-complex would compete for the remaining
diol 3 and the reaction rates during time period A would
alter depending on the concentrations of compounds 3
and  4. Since the experimental data do not display a
change of the reaction rates, only a non-competitive
mechanism remains possible. Diol 3 binds allosterically
whether the lipase is complexed or not. Therefore, we con-
clude that the lipase from M. miehei can be modulated
non-competitively at an allosteric binding site.
Conformation thesis
The described allosteric modulation does not cause a
complete inhibition of the lipase but a change in substrate
selectivity. Allosterically bound diol 3 modifies the active
binding site of the lipase. As a result monoacetate 4 can-
not be acetylated during time period A. In spite of this
inhibition the lipase acetylates diol 3 without a change in
activity. Thus, binding of diol 3 at the allosteric binding
site does neither result in blocking of the active site nor in
complete inhibition of the enzyme as described in litera-
ture generally [15]. In fact the allosteric binding of diol 3
leads to a modified conformation of the lipase, which
allows only diol 3 to be bound at the active binding site.
Progress of the reaction carried out at +20°C using lipase  from M. miehei; Amount of compounds 3, 4 and 5 (n [%]);  The reaction course is divided into two time periods: a:  period A (compounds 4 and 5 do not bind to the lipase); b:  time period B (the reaction is competitive) Figure 9
Progress of the reaction carried out at -10°C using lipase 
from M. miehei; Amount of compounds 3, 4 and 5 (n [%]); 
The reaction course is divided into two time periods: a: 
period A (compounds 4 and 5 do not bind to the lipase); b: 
time period B (the reaction is competitive).
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Figure 11 shows the different conformations of the lipase
during time period A (Fig. 11a) and during time period B
(Fig. 11b) schematically.
These findings prove, that enzymes cannot just be
switched on and off allosterically, but act as regulatory
proteins controlling a metabolic system, a process that
was so far only theorized [16]. The existence of a regula-
tory system controlled by a lipase, the conformation of
which is changed allosterically, is described herein for the
first time. It requires flexible parts in the tertiary structure
of the enzyme, which were found in the computer simu-
lated structure of the lipase from M. miehei [9].
Since the lipase from M. miehei is well-investigated and
used commercially [2], it is surprising that the allosteric
modulation described herein was not detected so far. This
is probably due to the fact that a number of parameters are
necessary for the discovery. The reaction has to be carried
out contrary to its natural direction and the progress has
to be recorded by appropriate analytical techniques. In
order to perform the acetylation with a necessary low
lipase/inhibitor ratio the lipase needs to be highly active.
A good choice is an immobilized lipase, since otherwise
the reaction time is very long. Furthermore, we assume
that the structures of the compounds used in experiments
have to be very similar to the natural substrates (compare
Fig. 12).
The allosteric binding site is an exciting new target for the
development of ligands and even drugs, which bind
reversibly or irreversibly. If the allosteric modulation can
be stabilized permanently by use of such ligands, the
resulting modified lipase will catalyze reactions with an
increased selectivity. Even more challenging is the devel-
opment of ligands that bind to the allosteric binding site
without modifying the conformation of the lipase and
thereby preventing other compounds from inducing the
modulation too.
Theory
Biological function
The described discovery entails the question about the rel-
evance of this regulation mechanism in nature. Natural
substrates of lipases are triglycerides (TGs) that are hydro-
lyzed at their active site. The lipase from M. miehei belongs
to the large class of sn-1,3 specific lipases [1,2], which cat-
alyze the hydrolysis of ester groups in position 1 and 3 of
glycerol preferentially. Thus, primary products are 2-
monoglycerides (2-MGs) and free fatty acids (FFAs). 2-
MGs are rearranged into 1-monoglycerides (1-MGs) by
Conformation thesis of the allosteric modulation to explain  the progress of the reaction using lipase from M. miehei (Fig.  9); a: during time period A compound 3 binds allosterically  modifying the active binding site.; b: during time period B the  allosteric modulation is reversed Figure 11
Conformation thesis of the allosteric modulation to explain 
the progress of the reaction using lipase from M. miehei (Fig. 
9); a: during time period A compound 3 binds allosterically 
modifying the active binding site.; b: during time period B the 
allosteric modulation is reversed.
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Reaction schemes that explain the progress of the reaction  using lipase from M. miehei (Fig. 9); a: during time period A  compounds 4 and 5 do not bind to the lipase (indicated by  crosses).; b: during time period B the reaction is competitive Figure 10
Reaction schemes that explain the progress of the reaction 
using lipase from M. miehei (Fig. 9); a: during time period A 
compounds 4 and 5 do not bind to the lipase (indicated by 
crosses).; b: during time period B the reaction is competitive.
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non-enzymatic acyl migration, which takes more time
than the enzymatic process. Finally, the lipase catalyzes
the hydrolysis of the resulting 1-MGs to give the end prod-
ucts glycerol and FFAs. Within mammalian cells the
decomposition of 2-MGs is mainly carried out by monoa-
cylglycerol lipase (MGL), which is expressed in excess.
Cooperation of sn-1,3 specific lipases and sn-2 specific
MGL ensures complete hydrolysis of TGs. Organisms use
lipases in order to convert TGs into absorbable products.
In contrast to TGs and DGs the produced MGs, glycerol
and FFAs can be absorbed in the gastrointestinal tract. In
this manner, upon hydrolysis by pancreatic lipase, 80% of
consumed edible fat is absorbed as 2-MGs and 20% as
glycerol along with the respective amounts of FFAs during
human digestion [17-20]. It can be assumed that the
lipase from M. miehei fulfills the same task of making TGs
available as a source of energy.
A comparison of the natural substrates and their products
with compounds 3, 4 and 5 we used in the experiment
leads to an apparent structural analogy. As described we
investigated the reactivity of pentanetriol-derivatives
instead of propanetriol (= glycerol)-derivatives. In this
context diacetate 5  corresponds to a triglyceride (TG),
monoacetate 4 to a diglyceride (DG) and diol 3 to a 2-
monoglyceride (2-MG) (Fig. 12). In contrast to 2-MGs,
which are rearranged into 1-MGs by acyl migration, diol 3
is stable due to its silylether-moiety.
During evolution the lipase from M. miehei was certainly
not developed to transform the synthetically produced
compounds we used in our experiments. Since diol 3
induces the allosteric modulation in the experiments, 2-
MGs should accomplish the same task in nature (Fig. 13).
This assumption becomes even more striking considering
the possible biological relevance of this regulation mech-
anism. 2-MGs are the primary products of lipase catalyzed
hydrolysis and modify the lipase by allosteric modula-
tion. Thereby they control the hydrolysis of TGs. This
principle is generally known as feedback-inhibition for
other enzymes. However the allosteric modulation as
described herein does neither inhibit the lipase com-
pletely nor change its activity, but just prevent TGs and
DGs from binding at the active site (Fig. 13a). The obser-
vation of this mechanism is only possible by forcing the
reactions contrary to their naturally directed equilibria.
Otherwise it cannot be distinguished from a loss in activ-
ity, since the modulator (2-MG) would be formed contin-
uously resulting in a slowly increasing concentration and
a slowly decreasing activity of the lipase. A model of the
allosteric regulation mechanism is exemplarily shown in
Figure 14 by means of a membrane-bound lipase [21,22].
In this model the active site of the lipase is at the cell sur-
face whereas the allosteric binding site is located intracel-
lularly. TGs and DGs are hydrolyzed extracellularly and
the products (MGs, FFAs and glycerol) are absorbed. In
this system the extent of extracellular hydrolysis is con-
trolled by the concentration of the products inside of the
cell. Thus, the lipase hydrolyzes just as many TGs and DGs
as are actually needed. If the lipase from M. miehei is
responsible for making fat available as a source of energy
by catalyzing the conversion of glycerides, the allosteric
Conformation thesis of the allosteric modulation shown with  natural substrates; TG = triglyceride; DG = diglyceride; 2- MG = 2-monoglyceride; a: In case of modulation A only 2- MGs can bind to the active site and can be transformed into  DGs; b: In case of modulation B all compounds can bind to  the active site Figure 13
Conformation thesis of the allosteric modulation shown with 
natural substrates; TG = triglyceride; DG = diglyceride; 2-
MG = 2-monoglyceride; a: In case of modulation A only 2-
MGs can bind to the active site and can be transformed into 
DGs; b: In case of modulation B all compounds can bind to 
the active site. TGs and DGs can be hydrolyzed.
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b
Structural analogy of the compounds used in the experi- ments (a) and natural substrates (b); solid lines encircle large  lipophilic moieties (modified OH-groups), dashed lines encir- cle small hydrophilic moieties (free OH-groups); a: diacetate  5, monoacetate 4 and diol 3; b: triglyceride TG, diglyceride  DG and 2-monoglyceride 2-MG (stearic acid as fatty acid) Figure 12
Structural analogy of the compounds used in the experi-
ments (a) and natural substrates (b); solid lines encircle large 
lipophilic moieties (modified OH-groups), dashed lines encir-
cle small hydrophilic moieties (free OH-groups); a: diacetate 
5, monoacetate 4 and diol 3; b: triglyceride TG, diglyceride 
DG and 2-monoglyceride 2-MG (stearic acid as fatty acid).
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modulation of the lipase enables the organism to control
this procedure.
Classification of lipases
As shown in with this article, obviously two different types
of lipases are found in nature. Type-1 lipases, e.g. the
lipase from B. cepacia, which hydrolyze TGs to a large
extent without further control, and type-2 lipases, includ-
ing the lipase from M. miehei, that regulate the conversion
of glycerides depending on the concentration of sub-
strates. The allosteric modulation can be more or less
developed within different lipases, but for a better under-
standing only the two pure types are discussed in this arti-
cle.
In order to avoid the detrimental effects of FFAs known as
lipotoxicity [23,24] fatty acids (FAs) are bound to fatty
acid binding proteins (FABPs) intracellularly. The same is
done by albumin in the blood of mammals. However, this
immobilization can be ensured only to a limited extent.
Unlimited or uncontrolled hydrolysis of triglycerides
would lead to concentration peaks of FAs, which become
toxic as FFAs when FABPs are saturated. Therefore, a rea-
son for the development of different types of lipases was
possibly the need to avoid intoxication by FFAs released
during hydrolysis of TGs. Their enantioselectivity is an
indication for the possibility that the two types of lipases
originate from phospholipases to make TGs available as a
source of energy. All organisms that use lipases for this
purpose must be able to control the extent of TG hydroly-
sis, whether the lipase is membrane-bound or secreted.
The different mobility of organisms towards nutrient TGs
should have stimulated the development of diverse
lipases. An organism using unregulated type-1 lipases to
hydrolyze TGs must be able to remove its absorbing mem-
brane from the released products of hydrolysis when their
amounts achieve toxic concentrations. Accordingly, these
lipases are secreted and the organism departs from the
Organisms using type-1 or type-2 lipases to hydrolyze nutri- tional fat; a: Type-1 lipases hydrolyze fat to a large extent Figure 15
Organisms using type-1 or type-2 lipases to hydrolyze nutri-
tional fat; a: Type-1 lipases hydrolyze fat to a large extent. 
The lipase secreting organism can depart by active or passive 
movement.; b: Type-2 lipases are regulated allosterically, 
therefore they hydrolyze fat depending on the concentration 
of products.
= type-1 lipase
= type-2 lipase
fat
fat
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b
The allosteric regulation is exemplarily shown by means of a  membrane bound lipase Figure 14
The allosteric regulation is exemplarily shown by means of a 
membrane bound lipase. Triglycerides (TGs) and diglycerides 
(DG) cannot pass through the membrane, whereas 
monoglycerides (MGs), free fatty acids (FFAs) and glycerol 
(GLY) which are the products of hydrolysis can be absorbed. 
Due to the allosteric mechanism the lipase hydrolyzes just as 
many TGs and DGs as are actually needed.
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released products by active movement or by drifting (Fig
15a). It is also possible that the nutriment containing the
secreted lipase is carried along the absorbing membrane
as it takes place in the intestinal tract of many organisms
including humans [17-20].
In contrast to this an organism, which is immobile
towards the products of TG hydrolysis can hydrolyze TGs
and DGs profitably only by use of type-2 lipases (Fig 15b).
The allosteric regulation mechanism of type-2 lipases
keeps the concentration of the resulting products at a con-
stant, non-toxic level irrespective of the amount of availa-
ble TGs.
However both types of organisms shown schematically in
Figure 15 have a major disadvantage in common. Unlike
most of the organisms existing nowadays they cannot
accumulate storage fat. This ability requires both hydroly-
sis and synthesis of TGs depending on demand and sup-
ply of nutriment. Storage fat can be accumulated either
inside cells or inside inclusions surrounded by cells. In
both cases only type-2 lipases can regulate the storage due
to the immobility of the organism towards the products of
TG hydrolysis. Even type-1 lipases secreted just on
demand could not perform this task. Upon activation in
order to hydrolyze storage fat a type-1 lipase could not be
inactivated fast enough to stop this process as soon as
nutritional fat becomes available again. As a consequence
the concentration of FFAs would fluctuate reaching toxic
peaks. Hence, all organisms using storage fat necessarily
need allosterically regulated type-2 lipases and cannot
exist without.
Storage fat, lipases and endosymbiontic theory
Before discussing the control mechanism of fat metabo-
lism concerning present-day organisms, the evolution of
lipases that hydrolyze TGs intracellularly should be con-
sidered. Such lipases would soever hydrolyze phospholip-
ids as well and thereby prevent the assembling of
membranes. Additionally, both the development of a cat-
alyst inside a cell, which does not contain any TGs to be
hydrolyzed, and the accumulation of fat without a catalyst
to re-hydrolyze it are hard to understand. An answer may
be endosymbiosis, which is accepted as an essential event
during evolution [25-27]. If an organism producing a
type-2 lipase invades another cell, the type-2 lipase regu-
lates the hydrolysis of TGs and keeps the concentration of
products constant within the cell (Fig. 16a).
The arising new organism is able to accumulate TGs intra-
cellularly during times supply of nutriment is plentiful
and re-hydrolyze TGs on demand of energy. This is a
mutualistic symbiosis, as the effect is beneficial to both
endo- and exosymbiont. The endosymbiont is always pro-
vided with TGs and the exosymbiont can store TGs to use
supply more efficiently. The new organism shown sche-
matically in Figure 16 (a) has acquired an essential evolu-
tional benefit by this metabolic symbiosis compared to
those organisms shown in Figure 15. It is no longer
dependent on continuous supply of nutritional fat and
does not have to lapse into a resting state when food is
missing. In fact, it is able to keep its metabolism running
in times of reduced or ceased food supply not only surviv-
ing such time periods but even retaining the ability of
reproduction. Constant energy supply is an essential
requirement for the evolution of higher forms of life. The
localization of type-2 lipases and their genes remain to be
investigated, but are not relevant for further considera-
tion. It can be presumed that the genetic information of
the symbionts was possibly combined during evolution
(Fig. 16b).
It is conceivable that the endosymbiotic process took
place by invasion of a type-2 producing organism into a
a: Supposed endosymbiosis of an organism containing type-2  lipases Figure 16
a: Supposed endosymbiosis of an organism containing type-2 
lipases. As a result the allosteric regulation mechanism con-
trols the concentration of products of hydrolysis and fat can 
be accumulated. This is a mutualistic symbiosis, as the effect 
is beneficial to both endo- and exosymbiont.; b: A new kind 
of organism results from genetic combination of the symbi-
onts. The ability to accumulate and mobilize storage fat is 
maintained and provides a major benefit due to energy 
homeostasis.
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related one or into an organism producing type-1 lipases.
In the former case a fungus-like (Fig. 17a) and in the latter
case an animal-like organism is formed (Fig. 17b). If the
animal-like organism is no longer dependent on ingestion
due to the development of photosynthesis, type-1 lipases
are not required any longer and the organism can assem-
ble a cell wall whereby a plant-like organism results (Fig.
17c).
The regulation of fat metabolism in present-day fungi and
plants is rather unexplored. The validity of the endosym-
biontic process suggested herein remains to be investi-
gated.
Human fat metabolism
The scheme shown in Figure 17(b) is of particular rele-
vance for the human fat metabolism. Humans should not
only possess pancreatic lipase (HPL) as a type-1 lipase
making nutritional fat available, but also a type-2 lipase
that regulates the accumulation of adipose. Until recently,
the hormone-sensitive lipase (HSL) was supposed to be
the only lipase for hydrolysis of TGs [15]. The established
TG metabolism is shown in Figure 18 schematically. HSL
is activated by (nor)adrenaline induced phosphorylation
and should be a type-1 lipase according to our classifica-
tion.
Doubts about the assumption that HSL would be the only
storage fat hydrolyzing lipase are entitled, since the release
of adrenaline leads to several other effects in vivo, too.
Furthermore, though activation by hormone induced
phosphorylation is a kind of short-term regulation, deac-
tivation of HSL can definitely not take place fast enough,
since activation and deactivation requires a cascade of
reactions [28,29]. As already described, this delay would
temporarily lead to toxic concentrations of FFAs during
ingestion. The obvious existence of another lipase than
HSL for the mobilization of stored fat was shown by
means of HSL-deficient mice [30-32]. These mice were
viable and did not even develop overweight.
Recently Zimmermann et al. discovered a new TG lipase
that was termed adipose triglyceride lipase (ATGL) (offi-
cial name: patatin-like phospholipase domain containing
protein-2, PNPLA 2) [33]. Currently it is under investiga-
tion that ATGL is identical to desnutrin [34] and phos-
pholipase A2-ζ [35], which both were discovered in 2004,
too. ATGL-deficient mice have an increased adipose mass
and glucose use, accumulate large amounts of lipids, espe-
cially in the heart, and their energy homeostasis is highly
defective, which proves this lipase to be crucial for the
mobilization of adipose [36]. We assume that ATGL is the
type-2 lipase we proposed to be responsible for the regu-
lation of fat metabolism. ATGL contains a so-called pata-
tin domain common to plant hydrolases, which is a
further indication for our theory. Patatin is a protein from
potato tuber (Solanum tuberosum) that is known to exhibit
lipolytic activity [37]. The genetic relationship refers to the
common endosymbiotical origin of these enzymes. For
this reason type-2 lipases have to be more closely related
to each other than to type-1 lipases, like HSL. Recently
Possible formation of organisms upon endosymbiosis; a: An  organism originating from symbiosis of an organism contain- ing type-2 lipases and a cogenerous one is fungus-like; b: As  the former exosymbiot used type-1 lipases to hydrolyze  nutritional fat, an animal-like organism results Figure 17
Possible formation of organisms upon endosymbiosis; a: An 
organism originating from symbiosis of an organism contain-
ing type-2 lipases and a cogenerous one is fungus-like; b: As 
the former exosymbiot used type-1 lipases to hydrolyze 
nutritional fat, an animal-like organism results.; c: If the ani-
mal-like organism does not need nutritional fat, since it can 
produce metabolic energy by photosynthesis, it can assemble 
a cell wall and becomes plant-like.
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ATGL-like lipases were found in the fruit fly Drosophila
melanogaster [38] and the yeast Saccharomyces cerevisiae as
well [24]. A patatin-like lipase that initiates the break-
down of storage oil was discovered in seeds of the thale
cress Arabidopsis thaliana [39]. All these lipases are closely
related to the lipase from the mold Mucor miehei that was
investigated in this article [39-41]. All of them are
encoded by homologous genes and are responsible for
energy homeostasis. Their pivotal role in lipolytic catabo-
lism was shown in further studies [42].
According to our theory, these lipases must be type-2
lipases and are therefore regulated by allosteric modula-
tion like the lipase from M. miehei. Another indication
supporting our theory is the observation that patatin- and
ATGL-like lipases paradoxically hydrolyze TGs and DGs
only to a low extent in vitro [39,43]. This is explained by
the allosteric mechanism presented in this article. Since
the products of TG hydrolysis are not consumed in these
experiments, the hydrolytic activity of the enzymes is
inhibited to prevent toxic concentrations of FFAs.
We assume that the human fat metabolism is regulated by
the same allosteric mechanism as demonstrated for the
lipase from M. miehei. We further assume that the modu-
lation is carried out by products of TG hydrolysis, which
can pass membranes to provide cells with energy. Thereby
nutritional fat, adipose and products of TG hydrolysis are
balanced to ensure energy homeostasis. This homeostasis
is shown schematically in Figure 19, which is an update of
Figure 18 supplemented by the recently discovered ATGL.
The assumption of an allosteric ATGL regulation in the
way we demonstrated herein leads to the following conse-
quences. During the absence of food ATGL keeps the con-
centration of products of TG hydrolysis constant as
generally described for type-2 lipases. When edible fat is
ingested with nutrition, human pancreatic lipase (HPL)
catalyzes its hydrolysis. The products of TG hydrolysis, in
particular 2-MGs, immediately induce allosteric modula-
tion of ATGL. This modulation leads to a modification of
the active binding site preventing further hydrolysis of
storage fat. The mechanism prevents fluctuations and thus
toxic concentrations of FFAs [23,24]. Furthermore, ATGL
is still able to store the temporary occurring excess of
products of TG hydrolysis according to the 2-monoacylg-
lycerol pathway, since the allosteric modulation does not
inhibit the lipase completely but just prevents TGs and
DGs from binding at its active site (compare Fig. 13).
Thereby an excess of nutrition (energy) is stored as adi-
pose and lipotoxicity is avoided. ATGL with the proposed
properties of a type-2 lipase enables organisms, including
humans, to maintain energy homeostasis irrespectively of
food supply. The severe consequences of a dysfunction of
this mechanism were shown with ATGL-deficient mice
[36]. Due to the absence of a regulative lipase these mice
are not provided sufficiently with energy when nutrition
is interrupted even though their body fat is increased. As a
Scheme of the human fat metabolism as supposed according  to our hypothesis Figure 19
Scheme of the human fat metabolism as supposed according 
to our hypothesis. Human pancreatic lipase (HPL) hydrolyzes 
nutritional fat. The recently discovered adipose triglyceride 
lipase (ATGL) is rate limiting for the mobilization and storage 
of adipose. We assume that ATGL is regulated allosterically 
in the way we demonstrated herein. Irrespective of food sup-
ply this regulation mechanism keeps the concentration of the 
products of hydrolysis constant and maintains energy home-
ostasis. Hormone-sensitive lipase (HSL) is of minor impor-
tance.
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Schematic pathways of the human fat metabolism established  until 2004 Figure 18
Schematic pathways of the human fat metabolism established 
until 2004. Nutritional fat is hydrolyzed by human pancreatic 
lipase (HPL) to produce 2-monoglycerides, glycerol and free 
fatty acids, which are absorbed. In addition to glucose these 
products provide metabolic energy directly or they can be 
transformed into adipose. Adipose is mobilized by hormone-
sensitive lipase (HSL).
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result they show defective cold adaptation, which is life-
threatening shortly after. The minor importance of HSL is
shown with HSL-deficient mice as mentioned above.
Obviously, it is just activated on demand, which is plausi-
ble due to its adrenaline induced activation associated to
stress.
Another phenomenon is explained by our theory. Partial
substitution of TGs by DGs in edible oils promotes weight
loss and reduction of body fat [44]. These diacylglycerol
enriched oils, which are termed DAG-oils [45], are com-
mercially available as food additives. Due to acyl migra-
tion DAG-oils mainly consist of 1,3-disubstituted DGs,
which means that the products of hydrolysis contain a
lower concentration of 2-MGs. Since according to our
hypothesis 2-MGs are a major factor for the allosteric
modulation of ATGL, this process is reduced leading to an
increased mobilization of adipose.
It is well established that glycerides are synthesized via the
2-monoacylglycerol pathway as well as the α-glycero-
phosphate pathway [46,47] and that the 2-monoacylglyc-
erol pathway is preferentially used in adipose tissue
[48,49]. 35 years ago it was shown that 2-MGs as well as
2-monoether analogues (2-MEs), which were used due to
their resistance to hydrolysis, are acylated via the 2-
monoacylglycerol pathway and seemingly inhibit the α-
glycerophosphate pathway [50]. Because of the observed
change of the pathway it was reasoned that 2-MGs may be
important in the regulation of TG biosythesis, but the
mechanism remained unknown. Today it is known that
ATGL is expressed predominantly in adipose tissue [33]
and the described findings can be explained with our the-
ory. The used 2-MGs and 2-MEs induce modulation A of
the lipase allosterically (compare Fig. 13a) and the only
reaction that is catalyzed by the enzyme is the acylation of
2-MGs.
The metabolic syndrome
The prevalently combined occurrence of obesity, hyper-
tension, type 2 diabetes, high cholesterol level, gallblad-
der diseases, arteriosclerosis and cardiovascular diseases
with an increased risk of heart attack and stroke is known
as the metabolic syndrome [51-54]. Over the past decades
the number of people suffering from the metabolic syn-
drome dramatically increased in industrialized countries.
Therefore, numerous large-scale studies and statistics were
performed and evaluated resulting in more than 12,000
articles and about 4,000 reviews on this subject during the
last ten years (hits in PubMed). But in spite of intensive
research activities reasons for the combined occurrence of
these diseases as well as any correlations remain rather
unknown. According to our hypothesis, a reduced expres-
sion rate of ATGL as a single reason is the crucial factor for
the development of the various diseases within the meta-
bolic syndrome
The activity of a certain amount of an enzyme is deter-
mined by short-term regulation, whereas the amount of
an enzyme is controlled by the rate of gene expression,
which is determined by long-term regulation [15]. The
rate of expression depends on genetic disposition and age,
but also on adaptation to the demand of metabolism. In
case of low demand for mobilization of adipose, since
energy is permanently available from nutrition, the
expression rate of the corresponding lipase ATGL is
accordingly decreased. Thus, deficient exercise and insuf-
ficient physical training combined with permanent nutri-
tion result in down-regulation of ATGL. As the relative
amount of 2-MGs produced by hydrolysis of TGs does not
change, the available ATGL activity is decreased resulting
in a slowdown of ATGL-catalyzed reactions. The most
obvious consequences are an increased amount of adi-
pose and the development of obesity.
If under the conditions of decreased ATGL activity the
demand of metabolic energy is suddenly increased for a
short time, the low amount of ATGL cannot provide the
organism with sufficient energy. Due to Figure 19 there
are some possibilities to circumvent the deficient energy
state.
In order to improve the energy supply of the organism
more blood must be transported into the consuming cells,
since it contains a less amount of nutritive substances
(FFAs). As a result the blood pressure is increased and
hypertension is developed.
Nutritional fat can be used to a greater extent. For that pur-
pose it has to be emulsified more efficiently by bile acids,
which are derived from cholesterol. The increased
demand of cholesterol results in an increased blood cho-
lesterol level. Furthermore, the increased production of
bile acids can cause gallbladder diseases.
HSL can be activated to a greater extent to hydrolyze a
greater amount of adipose. As above-mentioned this leads
to increased fluctuations of the concentration of FFAs.
Toxic peaks result especially upon ingestion causing lipo-
toxicity. This effect is even reinforced, since in addition to
that the ability of ATGL to store the excess of FFAs is
reduced due to its lower amount. Since the solubility of
FFAs in blood is limited, they are transported bound to
albumin [15]. The temporarily increased concentration of
FFAs in the blood increases the risk of interactions with
the endothelial cells of the blood vessels. This mainly con-
cerns the arteries due to the higher amount of FFAs
therein. Deposits can be accumulated causing arterioscle-
rosis and an increased risk of heart attack and stroke.Theoretical Biology and Medical Modelling 2007, 4:34 http://www.tbiomed.com/content/4/1/34
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Stress combined with an increased concentration of
adrenaline can also cause these effects, since HSL is acti-
vated to a greater extent.
The low energy level of the blood can also be compen-
sated by increasing the concentration of glucose. A non-
insulin-dependent hyperglycemia emerges which can be
medicated but not cured (type 2 diabetes). Nutrition con-
taining large amounts of carbohydrates or sugar also pro-
motes the use of glucose instead of fat as a supply of
energy, which results in the effects mentioned herein.
The suggestion to enhance physical exercise for preven-
tion of the metabolic syndrome remains unchanged
[55,56]. Maybe similar effects can be achieved by a change
of the eating habits, which often include an all-day long
permanent nutrition. Periods of hunger also result in an
increased stimulation of ATGL expression by the need to
immobilize adipose.
According to our theory a medicinal treatment of the met-
abolic syndrome seems to be difficult, since the ATGL
expression rate cannot be increased in this way. Neverthe-
less, two possibilities should be mentioned here. The con-
centration of 2-MGs resulting from the hydrolysis of
nutritional fat could be decreased by use of a 2-MG selec-
tive lipase, like the lipase from Bacillus stearothermophilus
[57,58], which has to be applied in a gastro-resistant form.
Secondly, ligands could be developed that bind to the
allosteric binding site without modifying the conforma-
tion of the lipase and thereby preventing other com-
pounds from inducing the modulation.
In conclusion, the diseases within the metabolic syn-
drome are described in a highly simplified manner. How-
ever, explanation of the metabolic syndrome by just one
reason, a decreased ATGL expression, represents a striking
idea. Although, a lot of work has to be done to prove or
disprove this theory and to find and optimize potent
ATGL ligands binding allosterically, this theory should
stimulate further research in the field of fat metabolism,
which is a very up to date topic [59]. Moreover, this theory
provides a novel starting point for the development of
innovative therapeutic strategies [60].
Methods
Chemical compounds
Dimethyl 3-hydroxyglutarate 1  (CAS 7250-55-7) was
silylated and the resulting dimethyl 3-(dimethylphenylsi-
lyloxy)glutarate  2  was reduced by LiBH4  to give 3-
(dimethylphenylsilyloxy)pentane-1,5-diol 3 as described
in literature [13]. Enzymatically produced [3-(dimethyl-
phenylsilyloxy)-5-hydroxypentan-1-yl] acetate 4 and [3-
(dimethylphenylsilyloxy)pentane-1,5-diyl] diacetate 5 are
also characterized in this article.
Reaction courses
The following procedures were carried out to observe the
progress of the reactions according to literature [13].
Enzymatic transformations
Employed lipase preparations:
Amano PS-CII (lipase from Burkholderia cepacia) by
Aldrich®
Lipozyme® (lipase from Mucor miehei) by Fluka®
General:
In a 50 mL two-necked flask diol 3 (about 280 mg) was
dissolved in TBME (30 mL) and the respective lipase was
added (0.50 or 1.00 weight equivalents). To avoid dam-
age of the ceramic particles the reaction mixture was
stirred with a KPG-stirrer (100 rpm). The given reaction
temperature was adjusted by a cryostat (20°C, -10°C or -
40°C) and the reaction was started by addition of the
respective amount of isopropenyl acetate (IPA) (5.00 or
15.0 equivalents). The exact reaction conditions are listed
in Table 1.
Preparation of samples
In order to analyze the transformation samples (100 µL)
were taken from the reaction mixture, filtered through a
membrane filter (0.45 µm) and the solvent was evapo-
rated in a nitrogen stream during 2 min. The residue was
dissolved in 100 µL of acetonitrile for HPLC method 1
and in 100 µL of a n-hexane/propan-2-ol 9:1 mixture for
HPLC method 2.
Table 1: Reaction conditions of the enzymatic transformations
Figure lipase preparation amount of lipase [mg] amount of diol 3 [mg] amount of IPA [µl] temperature [°C]
5 a, b Amano PS-CII 139.5 288.7 629 20
5 c, d Lipozyme® 138.0 275.9 597 20
6 a, b Amano PS-CII 291.8 291.5 1715 -40
6 c, d Lipozyme® 142.0 283.5 614 -10Theoretical Biology and Medical Modelling 2007, 4:34 http://www.tbiomed.com/content/4/1/34
Page 15 of 16
(page number not for citation purposes)
HPLC Methods
Method 1 (achiral)
column: Merck LiChrospher 100 RP-18e (5 µm); 125 - 4
mm.
mobile phase: acetonitrile/water 50:50; 1 mL/min.
detection: λ = 264 nm for 16 min.
retention times (rt): rt (3) = 1.9 min; rt (4) = 4.1 min; rt
(5) = 12.4 min.
scaling factors (sf): sf (3) = sf (4) = sf (5) = 1.00 [n (%)/
area (%)].
Method 2 (chiral)
column: Daicel Chiralpak AD-H (5 µm); 250 - 4.6 mm.
mobile phase: n-hexane/propan-2-ol 51:1; 1 mL/min.
(After 40 min the column was purged with n-hexane/pro-
pan-2-ol 9:1 and re-equilibrated.)
detection: λ = 264 nm for 40 min.
retention times (rt): rt ((S)-4) = 25.0 min; rt ((R)-4) = 27.5
min.
The rt can be increased by using n-hexane/propan-2-ol
54:1 to rt ((S)-4) = 27.5 min; rt ((R)-4) = 32.5 min.
scaling factors (sf): sf ((S)-4) = sf ((R)-4) = 1.000 [n (%)/
area (%)].
Computer simulations
The Microsoft® Excel table used to simulate competitive
desymmetrizations (Fig. 5e, f, Fig. 6e, f and Fig. 8a, b, c, d)
was published recently and is available as supplementary
material [14]. The abbreviations of compounds E, P and
W used in that article simply have to be replaced by the
compound numbers used herein as follows: E = 3; PS =
(S)-4; PR = (R)-4; W = 5.
In order to simulate a non-competitive reaction (Fig. 8e,
f) the computation has to be modified. Differing from lit-
erature [14] the changes of the amounts of substances dur-
ing a time interval are calculated as follows: ∆n(3)i = - a ;
∆n((S)-4)i = a·d ; ∆n((R)-4)i = a·e ; ∆n(5)i = 0.
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